Cargando…
Anlotinib combined with TAS-102 as the third-line treatment for a patient with metastatic colon cancer: A case report
Chemotherapy combined with targeted therapy is a first-line and second-line treatment for metastatic colorectal cancer(mCRC), which has brought survival benefits to mCRC patients, however, disease progression is inevitable. More than 60% of patients still needed third-line treatment after the progre...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748473/ https://www.ncbi.nlm.nih.gov/pubmed/36531025 http://dx.doi.org/10.3389/fonc.2022.978005 |